Oncology Books

1417 products


  • Amazon Digital Services LLC - Kdp Estrogens Shadow

    15 in stock

    15 in stock

    £15.99

  • Independently Published Ce Sein Qui Bat

    15 in stock

    15 in stock

    £12.83

  • Amazon Digital Services LLC - Kdp Breathless No More

    15 in stock

    15 in stock

    £15.99

  • Amazon Digital Services LLC - Kdp Fighting Cancer with Food and Fasting

    15 in stock

    15 in stock

    £15.09

  • Amazon Digital Services LLC - Kdp Melanoma Survival Guide

    15 in stock

    15 in stock

    £15.27

  • Amazon Digital Services LLC - Kdp Colon and Rectal Cancer Explained

    15 in stock

    15 in stock

    £15.99

  • 15 in stock

    £10.57

  • Hoffman and Abeloffs HematologyOncology Review

    Elsevier - Health Sciences Division Hoffman and Abeloffs HematologyOncology Review

    3 in stock

    Book SynopsisTable of ContentsIsaacs: Hoffman and Abeloff's Hematology-Oncology Review 1. Cancer biology and Genomics 2. Tumor Immunology 3. Anti-Cancer Therapies SECTION 1: Chemotherapy SECTION 2: Immunotherapy, antibodies, vaccines and pathway inhibitors 4. Clinical Trial Design and Ethics 5. Hereditary Cancer Syndromes HEMATOLOGIC MALIGNANCIES 6. Acute Myeloid Leukemia and Myelodysplastic Syndrome 7. Myeloproliferative Disorders 8. Chronic Lymphocytic Leukemia, Hairy Cell Leukemia, and other Chronic Lymphoproliferative Disorders 9: Hodgkin lymphoma 10. Non-Hodgkin Lymphoma 11. Multiple myeloma and other plasma cell dyscrasias 12. T cell and NK cell neoplasms and other lymphoid malignancies 13. Hematopoeietic Cell Transplantation SOLID TUMOR MALIGNANCIES 14. Breast cancer a: Early Stage Breast Cancer b: Metastatic breast cancer e. Premalignant breast conditions and in situ disease 15. Lung Cancer a: Non-small cell lung cancer b: Small cell lung cancer 16. Other Thoracic Malignancies a: Mesothelioma b: Thymoma and thymic cancer 17. Head and Neck cancer 18 : Esophageal Cancer 19: Gastric cancer 20: Pancreatic cancer 21: Colorectal cancer and Anal Cancer 22: Hepatobiliary cancer 23: Neuroendocrine, small bowel and appendiceal malignancies 24. Prostate cancer 25. Bladder and other urothelial cancers 26. Renal Carcinomas 27. Germ cell tumors 28. Gynecological Malignancies Ovarian Cancer and Fallopian Tube Cancer Cancer of the Cervix, Uterus, Vagina, Vulva and Gestational Choriocarcinoma 29. Melanoma and other skin cancers 30. Bone and soft tissue sarcoma 31.Cancer of unknown primary site 32. . Malignancies of the Central Nervous System a. Primary b. Metastatic NONMALIGNANT HEMATOLOGIC CONDITIONS 33. Coagulation 34. Hematopoietic System 1: Hematopoietic System Disorders RBC or iron 35. Transfusion Medicine SURVIVORSHIP AND END OF LIFE CARE Chapter 36. Supportive Care

    3 in stock

    £71.99

  • Abeloffs Clinical Oncology

    Elsevier - Health Sciences Division Abeloffs Clinical Oncology

    10 in stock

    Book SynopsisTable of ContentsAbeloff's Clinical Oncology Sixth Edition PART I: SCIENCE AND CLINCIAL ONCOLOGY SECTION A: BIOLOGY AND CANCER 1. Molecular Tools in Cancer Research 2. Intracellular Signaling 3. The Cellular Microenvironment and Metastases 4. Control of the Cell Cycle 5. The Pathophysiology of Cancer Cell Death 6. Cancer Immunology 7. Stem Cells, Cell Differentiation, and Cancer 8. Vascular and Interstitial Biology of Tumors 9. Cancer Metabolism SECTION B: GENESIS OF CANCER 10. Environmental Factors 11. DNA Damage Response Pathways and Cancer 12. Viruses and Human Cancer 13. Genetic Factors: Hereditary Cancer Predisposition Syndromes 14. Genetic and Epigenetic Changes in Cancer SECTION C: DIAGNOSIS OF CANCER 15. Pathology, Biomarkers, and Molecular Diagnostics 16. Imaging SECTION D: CLINICAL TRIALS 17. Biostatistics and Bioinformatics in Clinical Trials 18. Trial Design 19. Structures Supporting Cancer Clinical Trials 20. Oncology and Health Care Policy SECTION E: PREVENTION AND EARLY DETECTION 21. Discovery and Characterization of Cancer Genetic Susceptibility Alleles 22. Lifestyle and Cancer Prevention 23. Cancer Screening and Early Detection 24. Nicotine Dependence: Current Treatments and Future Directions SECTION F: TREATMENT 25. Cancer Pharmacology 26. Therapeutic Targeting of Cancer Cells: Era of Molecularly Targeted Agents 27. Basics of Radiation Therapy 28. Hematopoietic Stem Cell Transplantation 29. Gene Therapy in Oncology 30. Therapeutic Antibodies and Immunologic Conjugates 31. Complementary and Alternative Medicine PART II: PROBLEMS COMMON TO CANCER AND THERAPY SECTION A: HEMATOLOGIC PROBLEMS AND INFACTIONS 32. Disorders of Blood Cell Production in Clinical Oncology 33. Diagnosis, Treatment, and Prevention of Cancer-Related Venous Thrombosis 34. Infection in the Patient with Cancer SECTION B: SYMPTOM MANAGEMENT 35. Hypercalcemia 36. Tumor Lysis Syndrome 37. Cancer-Related Pain 38. Cancer Cachexia 39. Nausea and Vomiting SECTION C: TREATMENT COMPLICATIONS 40. Oral Complications 41. Dermatologic Toxicities of Anticancer Therapy 42. Cardiovascular Effects of Cancer Therapy 43. Reproductive Complications 44. Paraneoplastic Neurologic Syndromes 45. Neurologic complications 46. Endocrine Complications 47. Pulmonary Complications of Anticancer Treatment SECTION D: POST TREATMENT CONSIDERATIONS 48. Rehabilitation of Individuals with Cancer 49. Survivorship 50. Second Malignant Neoplasms 51. Caring for Patients at the End of Life SECTION E: LOCAL EFFECTS OF CANCER AND ITS METASTASIS 52. Acute Abdomen, Bowel Obstruction, and Fistula 53. Superior Vena Cava Syndrome 54. Spinal Cord Compression 55. Brain Metastases and Neoplastic Meningitis 56. Bone Metastases 57. Lung Metastases 58. Liver Metastases 59. Malignancy-Related Effusions SECTION F: SPECIAL POPULATIONS 60. Cancer in the Elderly: Biology, Prevention, and Treatment 61. Special Issues in Pregnancy 62. Human Immunodeficiency Virus (HIV) Infection and Cancer PART III: SPECIFIC MALIGNANCIES SECTION A 63. Cancer of the Central Nervous System SECTION B 64. Ocular Tumors 65. Cancer of the Head and Neck SECTION C: SKIN 66. Melanoma 67. Nonmelanoma Skin Cancers: Basal Cell and Squamous Cell Carcinomas SECTION D: ENDOCRINE 68. Cancer of the Endocrine System SECTION E: THORACIC 69. Cancer of the Lung: Non-Small Cell Lung Cancer and Small Cell Lung Cancer 70. Diseases of the Pleura and Mediastinum 71. Cancer of the Esophagus and Gastroesophageal Junction SECTION F: GASTROINTESTINAL 72. Cancer of the Stomach and Gastroesophageal Junction 73. Cancer of the Small Bowel 74. Colon Cancer 75. Cancer of the Rectum 76. Cancer of the Anal Canal 77. Liver and Bile Duct Cancer 78. Carcinoma of the Pancreas SECTION G: GENITOURINARY 79. Cancer of the Kidney 80. Carcinoma of the Bladder 81. Prostate Cancer 82. Cancer of the Penis 83. Testicular Cancer SECTION H: GYNECOLOGICAL 84. Cancers of the Cervix, Vulva, and Vagina 85. Cancer of the Endometrium 86. Ovaries and Fallopian Tubes 87. Gestational Trophoblastic Disease 88. Cancer of the Breast SECTION I: SARCOMAS 89. Sarcomas of Bone 90. Sarcomas of Soft Tissue SECTION J 91. Carcinoma of Unknown Primary SECTION K: PEDIATRICS 92. Pediatric Solid Tumors 93. Childhood Leukemia 94. Childhood Lymphoma SECTION L: HEMATOLOGICAL 95. Acute Leukemias in Adults 96. Myelodysplastic Syndromes 97. Myeloproliferative Disorders 98. Chronic Myeloid Leukemia 99. Chronic Lymphoid Leukemias 100. Hairy Cell Leukemia 101. Multiple Myeloma and Related Disorders 102. Hodgkin's Lymphoma 103. Non-Hodgkin Lymphoma 104. Cutaneous T-Cell Lymphoma and Cutaneous B-Cell Lymphoma 105. Adult T-Cell Leukemia-Lymphoma

    10 in stock

    £258.29

  • Head and Neck Pathology

    Elsevier - Health Sciences Division Head and Neck Pathology

    4 in stock

    Book SynopsisTrade Review"a good friend for the wide pathology community" a good friend for the wide pathology communityTable of Contents1. Non-Neoplastic Lesions of the Nasal Cavity, Paranasal Sinuses, and Nasopharynx 2. Benign Neoplasms of the Nasal Cavity, Paranasal Sinuses, and Nasopharynx 3. Malignant Neoplasms of the Nasal Cavity, Paranasal Sinuses, and Nasopharynx 4. Non-Neoplastic Lesions of the Larynx, Hypopharynx, and Trachea 5. Benign Neoplasms of the Larynx, Hypopharynx, and Trachea 6. Malignant Neoplasms of the Larynx, Hypopharynx, and Trachea 7. Non-Neoplastic Lesions of the Oral Cavity 8. Benign Neoplasms of the Oral Cavity 9. Malignant Neoplasms of the Oral Cavity 10. Malignant Neoplasms of the Oropharynx 11. Non-Neoplastic Lesions of the Salivary Glands 12. Benign Neoplasms of the Salivary Glands 13. Malignant Neoplasms of the Salivary Glands 14. Non-Neoplastic Lesions of the Gnathic Bones 15. Benign Neoplasms of the Gnathic Bones 16. Malignant Neoplasms of the Gnathic Bones 17. Non-Neoplastic Lesions of the Ear and Temporal Bone 18. Benign Neoplasms of the Ear and Temporal Bone 19. Malignant Neoplasms of the Ear and Temporal Bone 20. Non-Neoplastic Lesions of the Neck (Soft Tissue, Bone, and Lymph Node) 21. Benign Neoplasms of the Neck (Soft Tissue, Bone, and Lymph Node) 22. Malignant Neoplasms of the Neck (Soft Tissue, Bone, and Lymph Node) 23. Non-Neoplastic Lesions of the Thyroid Gland 24. Benign Neoplasms of the Thyroid Gland 25. Malignant Neoplasms of the Thyroid Gland 26. Non-Neoplastic Lesions of the Parathyroid Gland 27. Benign Neoplasms of the Parathyroid Gland 28. Malignant Neoplasms of the Parathyroid Gland 29. Diseases of the Paraganglia System

    4 in stock

    £142.19

  • Practical Soft Tissue Pathology A Diagnostic

    Elsevier - Health Sciences Division Practical Soft Tissue Pathology A Diagnostic

    Book SynopsisTrade Review"this book belongs at the bookshelf (and tablet) of any pathologist getting acquainted with the systematic approach to the complex world of soft tissue tumours." This book belongs at the bookshelf (and tablet) of any pathologist getting acquainted with the systematic approach to the complex world of soft tissue tumours. "This excellent book could be considered as one of the key references in soft tissue pathology. It is a particularly excellent resource for pathology residents or fellows who are seeking a comprehensive but concise book on soft tissue pathology." Kyle Perry, MD (Henry Ford Health Systems) Doody's Score: 100-5 Stars!Table of Contents1. Introduction: Tumor Classification and Immunohistochemistry 2. Biologic Potential, Grading, Staging, and Reporting of Sarcomas 3. Spindle Cell Tumors of Adults 4. Pediatric Spindle Cell Tumors 5. Tumors with Myxoid Stroma 6. Epithelioid and Epithelial-like Tumors 7. Pleomorphic Sarcomas 8. Round Cell Tumors 9. Biphasic Tumors and Tumors with Mixed Patterns 10. Soft Tissue Tumors with Prominent Inflammatory Cells 11. Giant Cell-Rich Tumors 12. Adipocytic Tumors 13. Vascular Tumors 14. Cartilaginous and Osseous Soft Tissue Tumors 15. Cutaneous Mesenchymal Tumors 16. Mesenchymal Tumors of the Gastrointestinal Tract 17. Lower Genital Soft Tissue Tumors 18. Applications of Molecular Testing to Differential Diagnosis

    £210.59

  • IASLC Thoracic Oncology

    Elsevier - Health Sciences Division IASLC Thoracic Oncology

    Book SynopsisTrade Review"Overall, this is an outstanding resource that everyone interested in this subject must have.. The main objective of this book and the well-thought-out content sets it apart from any other book in the same space." Reviewed by Ravi Salgia, MD, PhD (City of Hope) Doody's Score: 98, 5 Stars!Table of ContentsSection 1: Lung Cancer Control and Epidemiology 1. Classical Epidemiology 2. Tobacco Control and Primary Prevention 3. Tobacco Cessation 4. Non-Smoking Related Lung Cancer 5. Gender-Related Differences in Lung Cancer 6. Genetic Susceptibility to Lung Cancer 7. Early Detection and Radiologic Screening 8. Preclinical Biomarkers for The Early Detection of Lung Cancer 9. Chemoprevention of Lung Cancer: Present and Developing Technologies Section 2: Lung Cancer Molecular Carcinogenesis 10. Copy Number Abnormalities and Gene Rearrangements in Lung Cancer: Present and Developing Technologies 11. Mutational Events in Lung Cancer: Present and Developing Technologies 12. Epigenetic Events, Alterations, and Remodeling in Lung Cancer: Present and Developing Technologies 13. Stem Cells and Lung Cancer: In Vitro and In Vivo Studies 14. Microenvironment and Lung Cancer 15. MicroRNAs as Biomarkers for Lung Cancer Section 3: Immunology 16. Humoral and Cellular Immune Dysregulation and Lung Cancer Section 4: Pathology 17. Classic Anatomic Pathology and Lung Cancer 18. Molecular Testing and Lung Cancer 19. Management of the Small Biopsy in the Molecular Er Section 5: Clinical and Radiologic Presentation of Lung Cancer 20. Clinical Presentation 21. Conventional Imaging Lung Cancer 22. PET Imaging of Lung Cancer Section 6: Diagnosis and Staging of Lung Cancer 23. Diagnostic Work-Up of Suspected Lung Cancer 24. Surgical Staging of the Mediastinum including Mediastinoscopy and Thoracoscopy, Preoperative and Intraoperative 25. The 8th Edition of the Tumor, Node and Metastasis Classification of Lung Cancer Section 7: Surgical Management of Lung Cancer 26. Preoperative Functional Evaluation of the Surgical Candidate 27. Results of Video Assisted Techniques for Resection of Lung Cancer 28. Results of Robotic Techniques for Resection of Lung Cancer 29. Extent of Surgical Resection for Stage I and II Lung Cancer 30. Extended Resections for Lung Cancer: Chest Wall and Pancoast Tumors 31. Extended Resections for Lung Cancer: Broncho/Vascular Sleeve Resections 32. Multiple Nodules: Management of the Patient with Synchronous or Metachronous Lung Cancers 33. Surgical Management of the Marginally Resectable Patient Section 8: Radiotherapeutic Management of Lung Cancer 34. Technical Requirements for Lung Cancer Radiotherapy 35. Radiobiology of Lung Cancer 36. Patient Selection for Radiotherapy 37. Stage I Non-Small Cell Lung Cancer and Oligometastatic Disease 38. Ablation Options for Localized Lung Cancer 39. Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer, including Combined Modality 40. Radiotherapy in the Management of Small Cell Lung Cancer: Thoracic Radiotherapy, Prophylactic Cranial Irradiation 41. Palliative Radiotherapy for Lung Cancer: Locoregional and Metastatic 42. Acute and Late Toxicities of Thoracic Radiotherapy: Pulmonary, Esophagus, Heart 43. Treatment-Related Neurotoxicity, Medical and Radiation Therapy Section 9: Chemotherapy and Targeted Agents for Lung Cancer 44. Front-Line Systemic Options in Non-Small Cell Lung Cancer 45. Systemic Options in Second Line and Beyond 46. Maintenance Therapy in NSCLC 47. Pharmacogenomics and Lung Cancer 48. New Targetable Pathways in Lung Cancer 49. Management of Toxicities of Targeted Therapies 50. Immunotherapy and Lung Cancer 51. Systemic Therapy in Early-Stage NSCLC 52. Treatment of Small-Cell Lung Cancer Section 10: Other Thoracic Malignancies 53. Malignant Mesothelioma 54. Mediastinal Tumors 55. Neuroendocrine Tumors of the Lung Other than SCLC 56. Thymic Cancer/Thymoma Section 11: Symptom Management and Complications 57. Lung Cancer Emergencies 58. Role of Palliative Care in Lung Cancer Section 12: Clinical Trials 59. Methodology of Clinical Trials in Lung Cancer 60. How to Promote and Organize Clinical Research in Lung Cancer Section 13: Thoracic Oncology Advocacy 61. Role of Advocacy Groups in Lung Cancer 62. Health Services Research in Lung Cancer Appendix 63. Appendix: Diagnostic Algorithms

    £209.79

  • OncoNephrology

    Elsevier - Health Sciences Division OncoNephrology

    4 in stock

    Book SynopsisTable of ContentsSECTION 1 Fluid and Electrolyte Disorders in Cancer Patients 1 Kidney Function 2 Dysnatremias in Cancer 3 Potassium Disorders 4 Calcium and Phosphorus Disorders 5 Volume Disorders and Fluid Resuscitation SECTION 2 Paraprotein-Related Kidney Diseases 6 Paraproteins 7 Cast Nephropathy 8 Systemic Light Chain Amyloidosis 9 Monoclonal Immunoglobulin Deposition Disease 10 Fibrillary and Immunotactoid Glomerulonephritis SECTION 3 Hematopoietic Stem Cell Associated Kidney Disease 11 Hematopoietic Cell Transplant Associated Kidney Injury 12 Sinusoidal Obstruction Syndrome 13 Thrombotic Microangiopathy 14 Graft-Versus-Host Disease 15 Chronic Kidney Disease, End-Stage Renal Disease, and Bone Marrow Transplant SECTION 4 Chemotherapy and Radiation Related Kidney Diseases 16 Conventional Chemotherapy 17 Targeted Cancer Therapies (Biologics) 18 Adverse Kidney Effects of Immunotherapies 19 Chemotherapy in Chronic Kidney Disease and Dialysis 20 Radiation Nephropathy SECTION 5 Paraneoplastic Glomerulopathies 21 Paraneoplastic Glomerular Diseases 22 Paraneoplastic Glomerulonephritis 23 Hematologic Malignancies 24 Cancer Screening Recommendations SECTION 6 Renal Tumors 25 Renal Cell Cancer 26 Wilms Tumor and von Hippel Lindau Disease 27 Tuberous Sclerosis Complex and the Kidney 28 Evaluation of a Renal Cyst/Mass SECTION 7 Acute Kidney Injury 29 Acute Kidney Injury Incidence, Pathogenesis, and Outcomes 30 Tumor Lysis Syndrome 31 Obstructive Nephropathy in Cancer 32 Renal Replacement Therapies SECTION 8 Chronic Kidney Disease and Cancer 33 Chronic Kidney Disease as a Complication of Cancer, With Special Focus on Kidney and Urothelial Tumors 34 Incidence of Cancer and Screening Recommendations 35 Cancer in Renal Transplant Patients SECTION 9 Kidney Infections 36 Renal Infections in Cancer Patients SECTION 10 Infiltrative Diseases 37 Kidney Disease in Leukemia 38 Kidney Disease in Lymphoma

    4 in stock

    £140.39

  • Handbook of Cancer TreatmentRelated Symptoms and

    Elsevier - Health Sciences Division Handbook of Cancer TreatmentRelated Symptoms and

    20 in stock

    Book SynopsisTable of ContentsPart 1. Cytotoxic Chemotherapy 1. Mechanism of Chemotherapy in Cancer Treatment 2. Neutropenic Complications of Chemotherapy 3. Chemotherapy Induced Anemia 4. Cancer Treatment Related Thrombocytopenia 5. Oral Mucositis 6. Gastrointestinal Complications of Chemotherapy 7. Neurological Complications 8. Pulmonary Toxicities of Cytotoxic Chemotherapy 9. Dermatological Complications of Chemotherapy 10. Cardiotoxicities of Chemotherapy 11. Management of Cancer Treatment Infusion Reactions Part 2. Targeted Therapies 12. Mechanism of Targeted Therapies in Cancer Treatment 13. Gastrointestinal Complications 14. Pulmonary Toxicities of Molecular Targeted Therapies 15. Dermatologic Toxicities 16. Cardiotoxicities Part 3. Immunotherapies 17. Mechanism of Immune-Related Adverse Events 18. Endocrine Toxicities 19. Gastrointestinal Toxicities 20. Neurological Complications of Immunotherapy 21. Pulmonary Toxicities 22. Dermatological Complications 23. Immunotherapy-Induced Cardiotoxicities 24. Rheumatological Complications Part 4. Radiation Therapy 25. Mechanisms of Radiation-Related Toxicities 26. Radiation-Induced Mucositis and Esophagitis 27. Radiation Therapy Related Dermatologic Toxicities 28. Pulmonary Toxicity from Radiation Therapy 29. Radiation-Induced Cardiotoxicities

    20 in stock

    £72.89

  • DiSaia and Creasman Clinical Gynecologic Oncology

    Elsevier - Health Sciences Division DiSaia and Creasman Clinical Gynecologic Oncology

    Book SynopsisTrade Review"This book provides a comprehensive overview of the clinical management of various gynecologic conditions. This tenth edition updates the previous version, which was published in 2018." ©Doody's Review Service, 2023, Sydney P Oesch, MD (University of Texas Southwestern Medical Center) Doody's Score: 4 Stars!Table of Contents1) Pre Invasive Disease of the Cervix a. Stu Massad 2) Pre Invasive Disease of the Vagina and Vulva and related disorders a. Cara Matthews and Joan Walker 3) Invasive Cervical Cancer a. Krish Tewari and Brad Monk 4) Endometrial Hyperplasia, Estrogen Therapy, and the Prevention of Endometrial Cancer a. Lisa Landrum and Rosemary Zuna and Joan Walker 5) Adenocarcinoma of the Uterine Corpus a. William Creasman and David Scott Miller 6) Sarcoma of the Uterus a. Scott McMeeken and William Creasman 7) Gestational Trophoblastic Disease a. Emma Barber and John Soper 8) Invasive Cancer of Vulva a. Thomas Herzog 9) Invasive Cancer of the Vagina a. Marilyn Huang, Brian Slomovitz and Rob Coleman 10) Adnexal Masses a. Camille Gunderson and Robert Mannel 11) Epithelial Ovarian Cancer a. Eric Eisenhauer, Ritu Salani and Larry Copeland 12) Germ Cell, Stromal and other ovarian tumors a. Emily Pennock, Chad Hamilton, Larr Maxwell and Charlotte Marcus 13) Fallopian tube cancer a. Eric Hope, G Larry Maxwell, and Chad Hamilton 14) Breast Diseases a. Patricia Cronin and Mary Gemignani 15) Cancer in Pregnancy a. Krish Tewari 16) Complications of Disease and Therapy a. Kemi Doll and Dan Clarkepearson 17) Basic Principles of Chemotherapy a. Christina Chu and Steve Rubin 18) Targeted therapy and Molecular Genetics a. Shannon Westin, Anil Sood and Rob Coleman 19) Genes and Cancer: Genetic Counselling and Clinical Management a. David Mutch, Sheri Babb and Phil Disaia 20) Palliative Care and Quality of Life a. Dana Chase, Siu-Fun Wong, Lari Wenzel and Brad Monk 21) Role of Minimally Invasive surgery in Gynecologic Malignancies a. Floor Backes, David Cohn, Robert Mannel and Jeff Fowler 22) Epidemiology of Commonly Used Statistical Terms and Analysis of Clinical Studies a. Wendy Brewster 23) Basic Principles in Gynecologic Radiotherapy a. Catheryn Yashar Appendix A: Staging: Staging of Cancer at Gynecologic Sites a) Mutch B: Modified from Common Terminology Criteria for Adverse events (common terminology criteria for adverse events). C: Blood component therapy D: Suggested recommendations for routine cancer screening E: Nutritional Therapy: Index

    £141.29

  • Diffusion MRI of the Breast

    Elsevier - Health Sciences Division Diffusion MRI of the Breast

    20 in stock

    Book SynopsisTable of ContentsIntroduction A- Basics of breast diffusion MRI - General principles and challenges of diffusion MRI (Le Bihan, Iima, Partridge) This section will provide the physical basis of Diffusion MRI, give the key concepts necessary to understand and use DWI in clinical practice B- Breast Clinical Applications - Overview of conventional breast imaging (MMG, US, MRI except DWI) (Mann and/or Kuhl) This chapter will give a general overview of the field of breast imaging, with pros and cons, to help positioning DWI among all other approaches - Overview of breast DWI: Diagnosis of suspicious lesions using DWI in combination with standard MRI (20 pages) (Baltzer, Clauser, Gilbert) This chapter will review how DWI is currently used as a breast imaging modality and how breast lesions appear with DWI - Biomarkers, prognosis and prediction factors (10 pages) (Iima, Moy) This chapter will explain how DWI could be specifically used to provide information on prognosis and prediction factors (eg Her, Pg, ER, Ki67 receptors expression) and help lesion management - Disease and treatment monitoring (10 pages) (Partridge, Hylton, Li) This chapter will provide guidance on how DWI can be used to manage breast lesions, from diagnosis to treatment monitoring, using examples for most common types of lesions - Diffusion MRI as a stand-alone unenhanced breast imaging approach and screening (10 pages) (Amornsiripanitch, Hee Jung Shin, Partridge) This chapter will foresee how DWI could be used as a stand-alone approach (without DCE): patient population, technical requirement - DWI and breast physiology status (menstrual cycle, pregnancy, lactation) (10 pages) (Iima, Nissan) This chapter will review how changes in hormonal context and physiology may affect appearance of DWI normal breast tissues and lesions C- Challenges and Advanced Techniques - IVIM/perfusion Non-Gaussian diffusion (20 pages) (Sigmund, Iima, Le Bihan) This chapter will show how tissue microcirculation (perfusion) can be obtained from DWI without the need for tracers or contrast agent, explain why boosting sensitivity to diffusion provides added contrast and information on tissue microstructure, and how to combine both approaches in a clinical setting - DTI (20 pages) (Sigmund, Partridge) This chapter will explain how Diffusion Tensor Imaging could potentially reveal oriented features in the breast (eg ducts) and how lesions might modify them - Tissue characterization, radiomics, Artificial Intelligence, multiparametric imaging and integration of diffusion MRI to BIRADS (20 pages) (Pinker, Morris) This chapter will explain how DWI could be combined to other advanced breast imaging approaches to provide higher sensitivity, specificity and prognosis - Novel/Alternative Acquisition Techniques - (20 pages) o DWIBS (Takahara) o MS-EPI, RS-EPI, SMS, RSI, etc - (Hargreaves) Those short chapters will provide glances at novel or alternative methods to perform DWI with specific focus for breast applications D- Let us get practical - Clinical interpretation of diffusion MRI, ROI assessment, common errors, pitfalls and artifacts, challenges in acquisition (20 pages) (Gilbert, Patterson) This chapter will provide guidance on the interpretation of DWI in the breast, qualitatively and quantitatively, showing how common errors can be avoided and artifacts corrected - Quality control, standardization, test-objects (20 pages) (Chenevert, Newitt, Malyarenko, Keenan) This chapter will provide guidance on how to optimize DWI protocols, verify and control settings to obtain accurate and reproducible results

    20 in stock

    £85.49

  • Manual of Hematopoietic Cell Transplantation and

    Elsevier - Health Sciences Division Manual of Hematopoietic Cell Transplantation and

    10 in stock

    Book SynopsisTable of ContentsPart One Introduction Ch 1 Evolution of HCT, past, present, and future Ch 2 Human leukocyte antigen Ch 3 Introduction and basic science of chimeric antigen receptor therapies Ch 4 Statistical methods in HCT and cellular therapies Part Two Methodology Ch 5 Hematopoietic cell collection; bone marrow harvesting, apheresis, UCB Ch 6 Leukapheresis and manufacturing of CAR cells Part Three General Clinical Aspects Ch 7 Patient and donor selection and preparing for HCT Ch 8 General management of patients undergoing HCT Ch 9 Haploidentical HCT Ch 10 Umbilical cord blood transplantation Ch 11 Process and general management of patients undergoing CAR therapies Part Four Pharmacology and Radiation Therapy Ch 12 Preparative regimens used in HCT and CAR therapies Ch 13 Pharmacology of drugs used in HCT and CAR therapies Ch 14 Role of radiation therapy in HCT and CAR therapies Part Five Disease-Specific Indications and Results Ch 15 HCT in AML Ch 16 CAR therapy in AML Ch 17 HCT in ALL Ch 18 CAR therapy in ALL Ch 19 HCT in chronic leukemias; CML and CLL Ch 20 HCT in MDS Ch 21 HCT in myeloproliferative disorders Ch 22 HCT in aplastic anemia Ch 23 HCT in multiple myeloma Ch 24 CAR therapy in multiple myeloma Ch 25 HCT in light-chain amyloidosis Ch 26 HCT in NHL Ch 27 HCT in Hodgkin lymphoma Ch 28 CAR therapy in lymphoma Ch 29 HCT in rare malignancies Ch 30 HCT for hematologic malignancies in HIV patients Ch 31 HCT in solid tumors Part Six Prevention and Management of Complications Ch 32 Infectious complications Ch 33 Graft failure Ch 34 Graft-versus-host disease Ch 35 Miscellaneous complications of HCT Ch 36 Cytokine release syndrome Ch 37 Neurologic complications of CAR therapy (ICANS) Ch 38 Miscellaneous complications of CAR therapy Ch 39 Symptoms management and palliative care Ch 40 Survivorship

    10 in stock

    £177.29

  • Diagnosis and Treatment of Rare Gynecologic

    Elsevier - Health Sciences Division Diagnosis and Treatment of Rare Gynecologic

    2 in stock

    Book SynopsisTrade Review"This is an easy-to-read resource on rare gynecological cancers for those in the field. Each chapter is comprehensive and self-standing, preventing flipping back and forth to other chapters to find pertinent material. There are useful figures and tables to summarize the content and to give an at-a-glance, quick view of the key information covered in the chapter. The book is very up to date and addresses all therapies that are currently used in gynecological cancers.The ebook is easy to navigate and provides access to the book in its entirety." ©Doody's Review Service, 2023, Dandi Huang, MD(Cedars-Sinai Medical Center). Doody's Score: 4 Stars!Table of ContentsContributor Information: Please list names/affiliations of any contributors (can be tentative): Section 1 - Ovarian Cancer Malignant Germ Cell Tumors Sex Cord-Stromal Tumors Malignant Mixed Mesodermal Tumor Clear Cell Carcinoma Mucinous Carcinomas Low-Grade Serous Tumors (MPSC) and Variants Small Cell (hypercalcemic) Other rare ovarian cancers (Small Cell Carcinoma (hypercalcemic), Small Cell Carcinoma (Neuroendocrine, Mesolthelioma, Squamous Cell, Sarcomas) Section 2 - Uterine Cancer Leiomyosarcoma Other sarcomas of the uterus (Endometrial Stromal Sarcoma, STUMP, adenosarcoma) Carcinosarcoma Uterine Serous Carcinoma Other rare uterine cancers (Choriocarcinoma, Yolk Sac, Neuroendocrine) Section 3 - Cervical Cancer High Grade Neuroendocrine Carcinoma Other rare cervical cancers (Verrucous Carcinoma, Clear Cell Carcinoma, Adenoid Cystic Carcinoma, Rhabdomyosarcoma) Section 4 - Vulvovaginal Cancers Clear Cell Carcinoma Melanoma Bartholin Gland Carcinoma Benign and Malignant Paget's Disease Other rare vulvovaginal carcinomas (Verrucous Carcinoma, Embryonal Rhabdomyosarcoma, Yolk Sac Tumor, Aggressive Angiomyxoma, Sarcomas Section 5 - Trophoblastic Disease Gestational Trophoblastic Disease and Placental Site Trophoblastic Tumor

    2 in stock

    £73.79

  • Palliative Radiation Oncology

    Elsevier - Health Sciences Division Palliative Radiation Oncology

    Book SynopsisTrade Review"This book addresses palliative care in radiation oncology from a multi-dimensional perspective and includes an ebook component. The website resources provide quick links to cited references, but offer limited additional features beyond the convenience of expanded access to the book." ©Doody's Review Service, 2023, Mark D. Hurwitz, MD (New York Medical College) Doody's Score: 4 Stars!Table of ContentsSECTION I Foundations and Principles of Palliative Care in Oncology 1 Definition of Palliative Care 2 Introduction to Prognostication 3 Basic Communication Frameworks 4 Troubleshooting Difficult Conversation 5 Models of Multidisciplinary Management SECTION II Techniques and Modalities 6 Palliative Radiation 7 Selecting Modalities 8 Treatment Planning in Palliative Radiotherapy 9 Alternate Modalities for Palliation 10 Combining Radiation and Systemic Therapy 11 Considerations Involving Reirradiation SECTION III Foundations and Principles of Palliative Radiation by Body Site or Special Population 12 Palliative Radiotherapy in the Head and Neck 13 Palliative Thoracic Radiation 14 Palliative Radiotherapy in the Breast and Chest Wall 15 Palliative Radiotherapy for Gastrointestinal Malignancies 16 Palliative Radiotherapy for Gynecologic Malignancies 17 Palliative Radiotherapy in Pediatrics 18 Radiotherapeutic Palliation of Lymphoma 19 Radiotherapeutic Palliation of Bone Marrow Diseases-Leukemia and Multiple Myeloma 20 Palliative Radiotherapy in Bones 21 Palliative Radiotherapy in the Brain 22 Palliative Radiotherapy in the Spine 23 Palliative Radiotherapy in Oligometastases 24 Palliative Radiotherapy in the Older Adult SECTION IV Management of Symptoms and Treatment- Related Toxicities 25 General Symptom Overview: Importance of Side Effect Management, CINV, Anorexia, and Cachexia 26 Management of Pain 27 Management of Fatigue 28 Management of Skin Toxicity 29 Central Nervous System: Symptoms and Toxicities 30 Management of Symptoms and Treatment-Related Toxicities of Head and Neck Cancers 31 Chest and Thorax: Symptoms and Toxicities 32 Abdomen and Pelvis: Symptoms and Toxicities 33 Late Toxicities Management 34 Psychosocial and Spiritual Distress Index

    £150.29

  • Diagnosis and Management of Hereditary Cancer

    Elsevier Science & Technology Diagnosis and Management of Hereditary Cancer

    1 in stock

    Book SynopsisTrade Review"Henson and Resta have compiled a thorough catalogue of clinically important cancer genes in a novel, accessible format that takes it to another level." --Jeffrey N. Weitzel, MD, Oncogenomicist for Precision PreventionTable of ContentsI. Genetics II. Genetic Testing III. Clinical Features IV. Tumors - Syndromes - Genes V. Classic Hereditary Cancer Syndromes

    1 in stock

    £106.20

  • The Lymphoid Neoplasms 3ed

    Taylor & Francis Ltd The Lymphoid Neoplasms 3ed

    Book SynopsisThis comprehensive and authoritative reference covers all aspects of the group of disorders collectively known as the lymphoid neoplasms. The reader is taken through a description of its normal cellular origins and the molecular genetic abnormalities that can lead to this group of conditions, a section of the book that has been considerably strengthened for this third edition, to the environmental factors that may be relevant to disease development, and, finally, to the pragmatic aspects of disease management. The authors synthesise for the reader apsects of current knowledge and likely future developments, and direct them to the appropriate resources should they wish to pursue particular avenues of scientific or literature research.Table of ContentsIntroduction. Epidemiology. Immunobiology. Classification and Pathogenesis. Pathology and Pathogenesis of Specific Lymphomas. Presenting Features, Diagnosis and Staging. General Principles of Management. Management of Specific Diseases. Future Directions in Diagnosis And Treatment.

    £275.50

  • B is for Breast Cancer

    Little, Brown Book Group B is for Breast Cancer

    5 in stock

    Book Synopsis''The day after I was diagnosed with breast cancer, I was standing in the chemist with a basket in my hand, blinking back tears and thinking, Now what does a breast cancer patient need? All I could come up with was waterproof mascara. I put some in my basket and thought someone should write an alternative guide to breast cancer. Step one - buy waterproof mascara. You''re going to need it. A few short months later, I found I was writing the guide myself. I sat in bed in between hospital appointments with my laptop, furiously, desperately trying to make sense of this alien world I had entered.''Written entirely while Christine Hamill was undergoing cancer treatment, this book is an honest and frank account of the emotional and physical impact of a cancer diagnosis. It is at turns funny, sad, angry and ultimately optimistic. Written without sentimentality, B is for Breast Cancer offers bite-size chunks of help and hope - a daily pep talk to anyone affected by the diseaseTrade ReviewAs a surgeon and Chairman of Cancer Focus Northern Ireland, I see women every day who are living with the impact of breast cancer. B is for Breast Cancer is a refreshing look at breast cancer from the woman's perspective. It is insightful, warm, moving and, in places, very funny. Other women will find this helpful and those of us who work in cancer services, or aspire to do so, should take a little time, put away the text book and try to walk in the shoes of the most important person of all - those living with the disease. It will help us all do what we do just a little better * Professor Roy Spence, Cancer Focus Northern Ireland *We know at Maggie's that when you are first diagnosed with cancer it can be a confusing and overwhelming time. There is so much information to take in, on everything from differing types of treatment and benefits to what's best to eat. That's why B is for Breast Cancer is such an important book. It breaks down all the questions you may have into clear and concise answers that are easy to read and not in the least bit intimidating. We will certainly make sure there are copies of the book in all our centres * Laura Lee, Chief Executive, Maggie’s Cancer Caring Centres *This is an alternative and informative guide to negotiating some of the challenges of being faced with breast cancer: an honest, humorous and ultimately hopeful insight into diagnosis, treatment and recovery * Dr Ruth Barr, Belfast *Patients living with and beyond cancer should find this book both useful and inspirational in that it addresses the many aspects of cancer which are not normally discussed in public or indeed in clinical practice. Christine has made sense of her feelings and reactions to her diagnosis and, with some degree of humour, written a very personal account. The book will also serve as a resource for staff working in clinical practice. I will be recommending it to my students in the hope that it will enhance their understanding of the cancer patient experience * Marie Glackin, Lecturer (Education – Cancer Nursing), School of Nursing and Midwifery, Queen’s University, Belfast *What a refreshingly honest read! In this very personal and vivid account of her cancer journey, I could identify with many aspects of my own experience. As well as humour, and some really useful observations on how to deal with things, there is anger, guilt and bags of fear and uncertainty. How I identified with the "howl-crying"! Christine reassures us that all this is normal and it is all right to talk about it, shout about it and cry about it. Above all she encourages us to get informed, seek support, ask the questions and not to accept platitudes. By writing in such a direct and honest fashion, Christine has paved the way for all those who are experiencing the trauma of diagnosis, treatment and beyond, to tell it how it really is and to come out the other side * Linda Shepherd, President, Cancer Support France (National) *An exceptional and personal account . . . which undoubtedly will bring comfort and reassurance to others who have just been diagnosed * Ulster Tatler *A book unlike anything else written on the subject * Belfast Telegraph *[It] mixes practical suggestions with an honest account of what she went through. It's funny, sad, optimistic - and very readable * Take a Break *Full of common sense and advice gleaned from her experience during diagnosis, treatment and recovery, it's humerous and honest * Irish News *Christine Hamill has a way of bringing humour to the trauma of cancer that no other author has dared to - which is why her first book, B is for Breast Cancer, has been such a big hit. * Belfast Telegraph *

    5 in stock

    £14.24

  • Understanding Cancer

    Taylor & Francis Ltd Understanding Cancer

    1 in stock

    Book SynopsisUnderstanding Cancer is a brand new undergraduate textbook for students without prior training in biology that integrates an introduction to cancer medicine with descriptions of the biological processes that go wrong to cause cancer's onset and progression. It also highlights the human side of cancer with stories of patients and loved ones touched by the disease, dealing with diagnosis, treatment, and the prospect of death as well as the broader societal aspects of cancer and its prevention. Key discoveries that have improved our understanding of cancer are presented in sidebars. In spite of this diversity, the book maintains precision and simplicity in describing what is and is not known about cancer, describing the strengths and limitations of current treatmentsTable of Contents1. Cancer and the Biology of Human Cells. 2. Cancer Detection, Diagnosis, and Prognosis. 3. The Organization of Normal Human Cells. 4. How Normal Cells Reproduce and Differentiate. 5. Factors that Promote the Cancerous Transformation of Cells. 6. Oncogenes and their Role in Cancerous Transformation. 7. Tumor Suppressors and their Roles in Resisting Carcinogenic Transformation. 8. Medical Treatment for Cancer. 9. The Immune System and its Relationship to Cancer. 10. A Perspective on "Cancer Futures". 11. Minimizing Cancer Risk. 12. Living with Cancer.

    1 in stock

    £104.50

  • Tumor Immunology Molecularly Defined Antigens and

    Taylor & Francis Ltd Tumor Immunology Molecularly Defined Antigens and

    1 in stock

    Book SynopsisAn introductory overview of the immunology of cancer including therapeutic approaches, this book will be an invaluable source for clinicians, researchers and students of immunology and molecular biology.Table of ContentsIntroduction. Immune Recognition of Cancer-Tumor Antigens. Processing and Presentation of Antigen for the Activation of Lymphocytes. Cellular Recognition of Tumors by T and NK Cells. Humoral Recognition of Cancer. Immunotherapy of Cancer. Tumor Evasion of Immune System.

    1 in stock

    £109.25

  • Tumor Antigens Recognized by T Cells and

    Taylor & Francis Ltd Tumor Antigens Recognized by T Cells and

    1 in stock

    Book SynopsisRecent progress in fundamental tumor immunology has led to immunotherapy trials in patients with solid tumors and hematological malignancies. In the past, immunotherapy approaches were primarily based on enhancement of tumor immunity with cytokines and adjuvant therapy, without knowledge of relevant tumor antigens. The discovery of tumor antigens capable of eliciting immune responses has now resulted in the development of antigen-specific immunotherapy strategies. Vaccination with defined peptide epitopes, purified proteins, cell components, and whole cells expressing defined tumor antigens provides an opportunity to measure antigen-specific immune responses in vaccinated patients, and to correlate immunity with clinical outcome.Tumor Antigens Recognized by T Cells and Antibodies provides a comprehensive overview of the molecular nature of tumor antigens that can be recognized by antibodies, helper T lymphocytes and cytotoxic T lymphocytes. Novel strategies to enhance ineffectiTable of ContentsTumor Antigens Recognized by Antibodies. Human Tumor Antigens Recognized by Antibodies (SEREX). Antibodies to Tumor Oncoproteins in Cancer Patients. Antibody and CTL Responses to the NY-ESO Antigen. Tumor Antigens Recognized by CD4+ T Cells (predominantly TH1). Melanoma Antigens Recognized by CD4+ T Cells. Mouse Models in the Recognition of Tumor Antigens. Antigens of the MAGE Family Recognized by CD4+ T Cells. Tumor antigens Recognized by CD8 T Cells. Melanoma Antigens Recognized by CD8 T Cells. Squamous Cells and Adeno Cancer Antigens Recognized by T Cells. Heat/Shock Proteins and Tumor Antigens. The Wilms Tumor Antigens as CTL Target. Ex vivo and in situ Tetramer Analysis of CTL Responses to Tumors. Altered Peptide Ligands of Tumor T Cell Epitopes: Implications for More Effective Vaccine Therapy in Human Neoplasia.

    1 in stock

    £166.25

  • Prognostic and Predictive Factors in Breast

    Taylor & Francis Ltd Prognostic and Predictive Factors in Breast

    1 in stock

    Book SynopsisThis title reviews the key prognostic factors in breast cancer, discussing the methodologies involved in measuring and reporting. It also examines the roles of major predictive markers such as the steroid receptors, p53 and HER-2. Given the wealth of information in the medical literature on breast cancer, this volume is useful in that it focuses strictly on these factors. That focus makes this text extremely useful for oncologists and researchers who want to learn more about best practices in prognoses.Table of ContentsIntroduction / Overview. Role of the Pathologist in Assessing Prognostic Factors for Breast Cancer. Determination and Significance of Lymph Node Occult Metastasis in Breast Cancer. Prognostic Value of Proliferation and Apoptosis in Breast Cancer. The Role of Cell-Cell and Cell-Stromal Interactions in Predicting Breast Cancer Behavior. Detection of Minimal Residual Disease in Predicting Outcome in Breast Cancer. Allelic Imbalance / Microsatellite Instability in Breast Cancers and Blood Determining Breast Cancer Behavior. The Use of Steroid Receptors in Predicting Response to Hormonal Therapy. MAP Kinase Family Members and Endocrine Response and Survival in Breast Cancer. p53 and Breast Cancer. Assessment of HER-2 and its Value in Breast Cancer.

    1 in stock

    £161.50

  • Extranodal Lymphomas Pathology and Management

    Taylor & Francis Ltd Extranodal Lymphomas Pathology and Management

    1 in stock

    Book SynopsisLymphomas classically manifest themselves in the lymph nodes but can also present in other bodily tissues or systems; the organ where exactly they present may make a very great difference to the strategy that should be adopted for their management. This topic has only recently been consistently addressed as an issue on its own, apart from the rest of the lymphomas, and this text is the first to apply modern systems of classification, diagnosis and management. This text is essential reading for hematologic oncologists and hematopathologists.Table of ContentsPart 1: Conceptual basis 1 Challenging issues in the management of extranodal lymphomas 2 Historical prospects for the concept of primary extranodal lymphoma 3 Epidemiology of primary extranodal lymphoma 4 Infectious etiopathogenesis of primary extranodal lymphoma 5 Lymphocyte homing and immunology of extranodal lympoid tissue 6 Specific management problems posed by the primary extranodal presentations. Part I – staging and response evaluation 7 Specific management problems posed by the primary extranodal presentations. Part I – local control of localized disease Part 2: Pathobiology and clinicopathological correlations 8 Pathobiology and molecular basis of MALT lymphoma 9 Principles of the WHO classification with special reference to aggressive extranodal lymphomas 10 MALT lymphoma pathology, initial diagnosis, and post-treatment evaluation Part 3: Main Entities/Locations 11 Primary central nervous system lymphoma 12 Primary testicular lymphoma 13 Intravascular large B-cell lymphoma 14 Nasal natural killer/T-cell lymphoma 15 Primary breast lymphoma 16 Bone lymphoma 17 Lung lymphoma 18 Primary mediastinal (thymic) large B-cell lymphomas 19 MALT-type lymphoma of the orbit and ocular adnexae 20 Primary marginal zone lymphomas and other non-MALT marginal zone lymphomas 21 Gastrointestinal tract lymphomas 22 Cutaneous lymphomas 23 Primary extranodal head and neck lymphomas 24 Lymphoma of the liver 25 Extranodal lymphomas in patients with HIV infection 26 Primary effusion lymphoma 27 Rare sites 28 Extranodal Hodgkin’s lymphoma

    1 in stock

    £194.75

  • Hepatocellular Carcinoma A Practical Approach

    Taylor & Francis Ltd Hepatocellular Carcinoma A Practical Approach

    1 in stock

    Book SynopsisAn essential resource for gastroenterologists, hepatologists, liver surgeons, hepatobiliary surgeons, oncologists, and all those working in the field of hepatocellular carcinoma (HCC), Hepatocellular Carcinoma: A Practical Approach covers the updates and recent developments on the diagnosis, screening, and comprehensive medical and surgical management of HCC.This one-of-a-kind textbook explores all aspects of the disease using a practical, evidence-based approach, and provides step-by-step treatment guidelines that are applicable to all clinical scenarios.Highlights in the text include: screening and surveillance methods to aid in the prevention of HCC imaging technologies for accurate diagnosis, including ultrasound and PET treatment modalities for HCC, such as local ablation therapy, chemoembolization, chemotherapy, and liver resection and transplantation a discussion on novel therapies and fuTrade ReviewThis volume covers comprehensively recent developments on the diagnosis, screening and medical and surgical of HCC, and is essential reading for gastroenterologists, hepatologists, liver surgeons, hepatobiliary surgeons, oncologists and other working in the field of HCC." - Anticancer research, April 2010 Table of ContentsEpidemiology, Pathogenesis, Surveillance, and Prevention: Epidemiology of the Hepatocellular Carcinoma. Molecular Pathogenesis. HCC Screening and Surveillance. Prevention of Hepatocellular Carcinoma. Diagnosis: Tumor Markers and Molecular Biology. Imaging of Hepatocellular Carcinoma. Staging. Management: Local Ablation Therapy. Chemotherapy and Novel Systemic Therapies. Chemoembolization, Radioembolization, and Other Novel Intra-arterial Therapies. Liver Resection. Liver Transplantation as Treatment for HCC.

    1 in stock

    £161.50

  • Review of Dialysis Care for Nurses and Dialysis

    £57.94

  • Facing Cancer and the Fear of Death

    Jason Aronson, Inc. Facing Cancer and the Fear of Death

    1 in stock

    Book SynopsisIn Facing Cancer and the Fear of Death: A Psychoanalytic Perspective on Treatment, Dr. Norman Straker proposes that âœdeath anxietyâ is responsible for the American societyâs failure to address costly futile care at the end of life.Trade ReviewIn Facing Cancer and the Fear of Death, the psychoanalyst Norman Straker...enriches the work enormously by allowing us to look into the minds of cancer patients, some our own colleagues, as they face these difficult and painful times. . . .[T]he varying voices combine to create an emotionally meaningful, deeply intelligent work. I think everyone, and not just therapists, should read this book. We all face death, many of us in the specter of cancer, and the experiences, difficulties, and resolutions described here could help us navigate the challenging times. * Journal of the American Psychoanalytic Association *In this compilation of essays, Norman Straker of Memorial Sloan-Kettering Cancer Center and his colleagues offers helpful perspectives into the widespread death anxiety that affects individual health care decisions as well as large-scale policy imperatives. ... The reader is provided with a unique opportunity to peer inside varying states of existential threat, guided by analysts of superior psychological insight. ... On the whole, the text is succinct, well written, and wide ranging in its sources of knowledge while staying grounded in psychiatric theory. Palliative care clinicians will likely find this book to be interesting and helpful. The issue of deciding the optimal use of the psychoanalytic frame (and which rules to break) has relevance for palliative care consultants who often navigate the difficult waters of end-oflife decision making. The psychiatric perspective featured in the book provides palliative care clinicians with a refreshing approach to understanding complex psychodynamics in various clinical settings. The personal essays as well as case presentations are bracing in their honesty and are invaluable sources of insight for all who care for seriously ill patients. * Palliative Medicine *The issues dealt with in this book are topical and real. It was interesting to read about the psychological needs in end-of-life care from a slightly different angle (i.e. by psychoanalysts), and the potential benefits of palliative care as viewed from outside our specialty. * IAHPC Newsletter *This is a much needed and remarkable book that is a must read for all therapists who treat cancer patients, and those therapists who unexpectedly may be facing the prospect of their own mortality. The elegiac and moving narratives of analysts treating cancer patients, and analysts who become cancer patients themselves, can profoundly inform and shape the reader’s appreciation of the need for flexibility of technique in these situations. The reader will also derive great benefit from Dr. Straker’s summary conclusions and recommendations, distilled from these stories and from his thirty five years of experience as a psychoanalyst working in the field of psycho-oncology. -- Stephen M. Saravay M.D., American Academy of Psychosomatic MedicineThis book provides a deeply personal yet strongly academic perspective on the experience of cancer. Dr. Straker has assembled a group of professionals who openly share their knowledge and experience. The depth of Dr. Straker's scholarly understanding envelopes the other contributions and provides an informed psychoanalytic framework. The book will be valuable to those who work with cancer patients and will be extremely useful in the education of trainees. -- Philip Muskin M.D., Columbia University Medical CenterAnxiety over dealing with death and the dying process affects patients, their families, friends, and physicians, often leading to inadequate and unsatisfying management of this inevitable, natural life event. The results of not dealing with “the elephant in the room” can have long-term adverse consequences on the survivors, including the physicians caring for the patient. Posttraumatic stress disorder, depression, guilt, and alcohol abuse may be the unfortunate legacies of dealing with death anxiety poorly. Dr. Norman Straker, who has devoted much of his career to managing the psychological needs of patients with cancer, as well as their families and caregivers, has produced a superb book on defining the causes and management of death anxiety. Using a combination of psychiatric theory, research results, and in-depth case studies, he and his colleagues present practical, flexible approaches to dealing with death and death anxiety in cancer patients. It is a book that will be especially useful to oncologists, radiation therapists, internists, psychologists, psychiatrists, and others who deal with death and dying. -- Glen D. Braunstein M.D., Cedars-Sinai Medical CenterTable of ContentsTable of Contents INTRODUCTION Norman Straker MD MEDICAL SECTION Chapter One: Where We Are Now The Avoidance OF Death, Its Consequences to Our Patients, Families, Medical Students, Young Physicians. Norman Straker MD Chapter Two: A Psycho Oncology Fellow’s Perspective On Facing Death David Yuppa MD & Norman Straker MD Chapter Three: Confronting the Fear of Death: Trying To Detoxify Norman Straker MD Two Memoirs Dan Birger MD, Hillel Swiller MD PSYCHOANALYTIC SECTION Chapter Four: The Denial Of Death by Psychoanalysts Norman Straker MD Chapter Five: Finding Meaning in Death: Terror Management Among the Terminally Ill Molly Maxfield, Tom Pyszczynski & Sheldon Solomon Chapter Six: The Psychoanalytic Literature On The Treatment Of Dying Patients Norman Straker MD Chapter Seven: An Update In The Psychoanalytic Treatment Of Cancer Patients Facing Death Norman Straker MD CASE PRESENTATIONS SECTION Chapter Eight: “That The Darkness Is About To Pass” The Treatment Of a Dying Patient Abby Adams Silvan PhD Chapter Nine: Guidelines to Live By and Rules To Break John W. Barnhill MD Chapter Ten: “Titration Of Psychotherapy For Patient And Analyst” Alison C Phillips MD Chapter Eleven: Psychotherapy With A Hospitalized Patient Dying Of Cancer M. Philip Luber MD Chapter Twelve: Being a Cancer Patient In Analysis, While Continuing To Work As An Analyst Patricia Plopa PhD CONCLUSION: Norman Straker MD References Index About the contributors

    1 in stock

    £77.90

  • Colorectal Cancer

    Taylor & Francis Inc Colorectal Cancer

    1 in stock

    Book SynopsisWritten by world authorities on the subject, this reference comprehensively covers every aspect of colorectal cancer. Addressing the molecular mechanisms, genetics, identification, and therapy of disease, this guide covers new pharmaceutical developments, current screening protocols, and modern methods of disease management by specialists at renowned institutions such as the Royal Marsden Hospital, the Memorial Sloan Kettering Cancer Center, and the Vanderbilt-Ingram Cancer Center.Table of ContentsGenetic Susceptibility to Colorectal Cancer. Epidemiology of Colorectal Cancer. Colorectal Cancer Screening. Pathology. Familial Cancer Management. The Surgical Principles of Managing Colorectal Cancer. Adjuvant Therapy for Colorectal Cancer. The Role of Radiotherapy in the Treatment of Rectal Cancer. Hepatic Directed Therapy. Pharmacogenomics of Colorectal Cancer. Drug Development for Advanced Colorectal Cancer in the U.S.

    1 in stock

    £171.00

  • Radionuclide Peptide Cancer Therapy

    Taylor & Francis Inc Radionuclide Peptide Cancer Therapy

    1 in stock

    Book SynopsisOffering lower toxicity and higher accuracy than conventional therapies, this source offers illustrative coverage of this new method to treat tumors associated with brain, breast, lung, and neuroendocrine cancers. Accompanied by a CD offering color images, radiolabeling procedures, and tips on radiopharmceutical administration, this source will offer comprehensive and expert guidance on this burgeoning therapeutic technique.Table of ContentsTHEORY AND PRODUCTION OF PEPTIDES FOR RADIONUCLIDE THERAPY. Peptide Structure and Analysis. Molecular Pharmacology of Receptors. Receptors Distribution and Biochemical Characterization. RADIOLABELING MECHANISMS AND STRATEGIES. Developments of Radiolabeled Peptides. Receptor Targeting for Tumor Therapy with Radiopeptides. New Radionuclides for Peptide Therapy. Pre-Clinical Comparison of Radiolabeled Peptides for Radionuclide Therapy. CLINICAL THERAPEUTIC APPLICATIONS. Phase I Therapeutic Studies. Response to Treatment with Radiolabeled Peptides. Receptor Radionuclide Therapy: From 90Y to 177Lu Labeled Peptides. Therapeutic Potential of Radiolabeled Peptides with Beta and Alpha Emitters. Receptor-Mediated Radionuclide Therapy: The European Institute of Oncology Experience. DOSIMETRIC ASPECTS AND REGULATORY REQUIREMENTS. Radiation Dosimetry in Preparation to Therapy. Dosimetry and Critical Organs. Regulatory Requirements for Therapy Trials. FUTURE PERSPECTIVES. Advances in the Field of Radiopeptides for Therapy

    1 in stock

    £171.00

  • Neoplasms of the Colon Rectum and Anus

    Taylor & Francis Inc Neoplasms of the Colon Rectum and Anus

    1 in stock

    Book SynopsisColorectal cancer is the second-leading cause of cancer-related death in the Western World. This Second Edition analyzes the genetics, mechanisms, and development of colorectal carcinoma and supplies the latest research and recommendations on the detection, treatment, and prevention of malignancies of the colon, rectum, and anus.Table of ContentsBenign Neoplasms of the Colon and Rectum. Large Bowel Carcinoma: Screening, Surveillance, and Follow-up. Malignant Neoplasms of the Colon. Malignant Neoplasms of the Rectum. Perianal and Anal Canal Neoplasms. Anal and Transanal Techniques. Laparoscopic Colon and Rectal Surgery.

    1 in stock

    £285.00

  • Metal Ions in Biological Systems

    Taylor & Francis Inc Metal Ions in Biological Systems

    5 in stock

    Book SynopsisOffering an authoritative and timely account by twenty-nine internationally recognized experts, Metal Ions in Biological Systems: Metal Complexes in Tumor Diagnosis and as Anticancer Agents is devoted solely to the vital research area concerning metal complexes in cancer diagnosis and therapy. In fourteen stimulating chapters, the book focuses on diagnostic tools such as magnetic resonance imaging (MRI), luminescent probes, and radiopharmaceuticals, including radiometallo-labeled peptides and assesses the role of metal ions, especially iron, in the action of antibiotics employed in anticancer chemotherapy.Trade Review"This is one of two recent volumes in a most successful series publishes since 1973 and which enjoys world renown and respect as both reference and as training material; the current volume is no exception. … [T]his is a gem of a book for both newcomers and established researchers in the field; long may they continue!" - Applied Organometallic Chemistry, 2005Promo CopyTable of ContentsMagnetic Resonance Contrast Agents for Medical and Molecular Imaging. Luminescent Lanthanide Probes as Diagnostic and Therapeutic Tools. Radio-Lanthanides in Nuclear Medicine. RadioMetallo-Labeled Peptides in Tumor Diagnosis and Therapy. Cisplatin and Related Anticancer Drugs. Recent Advances and Insights. The Effect of Cytoprotective Agents in Platinum Anticancer Therapy. Antitumor Activity of Trans-Platinum Species. Polynuclear Platinum Drugs. Platinum(IV) Anticancer Complexes. Ruthenium Anticancer Drugs. Antitumor Titanium Compounds and Related Metallocenes. Gold Complexes as Antitumor Agents. Gallium and Other Main Group Metal Compounds as Antitumor Agents. Metal Ion Dependent Antibiotics in Chemotherapy.

    5 in stock

    £285.00

  • NutrientGene Interactions in Cancer

    Taylor & Francis Inc NutrientGene Interactions in Cancer

    1 in stock

    Book SynopsisThe complete mapping of the human genome, along with the development of sophisticated molecular technologies, has accelerated research on the relationship between nutrients and genes. This has led to compelling evidence garnered from epidemiological and experimental observations supporting the idea that the interaction between nutrients and genes is one of the most important mechanisms influencing carcinogenesis. Nutrient-Gene Interactions in Cancer brings together leading authorities in the field who provide an overview and look specifically at the mechanisms known to underlie each nutrient and gene interaction. The book examines the multi-functional relationship linking nutrition and cancer development, including the complex role nutrients have in modulating cancer growth via interactions with specific genes, and the emerging new strategy for cancer chemoprevention that is based on a deepened understanding of this relationship. The authors also provide freshly illuminating inTable of ContentsNutrients and Genes Interaction. Candidate Mechanisms for the Nutrients and Gene Interaction. Biomarkers for Nutrients and Gene Interaction. Folate and Methylenetetrahydrofolate Reductase Gene. Folate and One-Carbon Metabolism Genes. Methionine and Methionine Adenosyltransferase. b -Carotene and Retinoic Receptor Genes. Vitamin D and Vitamin D Receptor Gene. Alcohol and Alcohol Dehydrogenase Genes. Meat and N-Acetyltransferase 2 Gene. Dietary Estrogens and Estrogen Receptor Genes. Ferritin and Serine Hydroxymethyltransferase Gene. Isothiocyanate and Glutathione S-Transferase Gene. Future Directions and Implication of Research on Nutrients and Gene Interactions in Cancer.

    1 in stock

    £199.50

  • Transformation of Human Diploid Fibroblasts

    Taylor & Francis Inc Transformation of Human Diploid Fibroblasts

    1 in stock

    Book SynopsisThis comprehensive publication draws together the important aspects of carcinogen-cell interaction. This interesting work describes the regulation of normal cell proliferation, cellular responses to carcinogen damage, the biologic consequences of cellular DNA modification, the structural and genomic changes resulting from carcinogen insult, and the possible involvement of such changes in the conversion of normal human fibroblasts to malignant cells. It presents current reviews with up-to-date literature references and provides critical information from leading investigators that is essential in understanding the biology of human cell transformation. This volume is especially useful to advanced students in genetic toxicology, molecular biologists, and all who are interested in the molecular and macromolecular changes in human cells leading to neoplasia.Table of ContentsPreface. Variations in Susceptibility to Initiation of Carcinogenesis During the Cell Cycle. Cell Cycle Regulation of DNA Repair Enzymes and Pathways. DNA Repair and Poly(ADP-ribose) Synthesis in Human Fibroblasts and Other Cell Types. Repair of O-Alkylation Damage in Human Cells. Ultraviolet Radiation-Induced Transformation of Human Cells. Biological Characterization and Quantitation of Markers of Transformation of Human Fibroblasts. Mechanisms for Cell Transformation and Carcinogenesis by Genotoxic and Nongenotoxic Agents: Role of Sodium Saccharin. Relationship Between Bulky Carcinogen-DNA Modification: Carcinogenesis and Mutagenesis. Metabolism of Polyaromatic Hydrocarbons by Human Fibroblasts. DNA Adducts and Human Cell Transformation. Cytotoxicity and Cell Culture. Mechanisms by Which Phorbol Ester Tumor Promoters Affect Gene Expression in Human Cells. Changes in Gene Expression Associated with Neoplastic Transformation of Human Fibroblasts: The Abundant Cellular Proteins. Differential Repair of Damage in Specific DNA Sequences of Human Cells. Index.

    1 in stock

    £285.00

  • Prostaglandin Inhibitors in Tumor Immunology and

    Taylor & Francis Inc Prostaglandin Inhibitors in Tumor Immunology and

    1 in stock

    Book SynopsisThis book provides an updated overview of eicosanoid metabolism. It also presents a timely discussion of eicosanoid metabolism in the process of tumor cell metastasis, in chemoprotection and radioprotection associated with cancer therapy, and in cell differentiation. The book focuses on the role of eicosanoids in the immunology of malignant disease. This includes how various immune cell populations in cancer are affected by the secretion and action of various eicosanoids and metabolites of eicosanoids and how these processes may be affected by various pharmacological manipulations and interventions to augment anti-tumor immunity. Head and neck cancer is covered in great detail to illustrate a cancer in humans where these considerations are particularly relevant. This important volume demonstrates that the principal factor in cancer patient immunologic deficiency is related to excess secretion by monocytes of prostaglandins.Table of ContentsCyclooxygenase and Lipoxygenase Pathways of Arachidonic Acid Metabolism (W.L. Smith and O. Laneuville). Participation of Lipoxygenase Products in Lymphohematopoietic and Other Cell Proliferation and Differentiation (K.M. Anderson, M. Wiederhold, and F. Ondrey). Eicosanoids and Tumor Cell Metastasis (D.G. Tang and K.V. Honn). The Impact of Prostaglandins on Cancer Patient Immunity (D.P. Braun and J.E. Harris). Prostaglandins and Host Immune Response in Squamous Cell Carcinoma of the Head and Neck (D.S. Cross, F. Ondrey, S.K. Juhn, and G.L. Adams). Eicosanoid-Induced Radioprotection and Chemoprevention of Normal Tissue During Cancer Treatment (W.R. Hanson). Prostaglandins and the Host Immune System: Application of Prostaglandin Inhibitors for Cancer Immunotherapy (P.K. Lala and M.-N. Saarloos).

    1 in stock

    £351.50

  • Inner Traditions Bear and Company When Healing Becomes a Crime

    2 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    2 in stock

    £24.30

  • Robbery and Redemption

    Baywood Publishing Company Inc Robbery and Redemption

    1 in stock

    Book SynopsisFirst Published in 2017. This volume is a totally candid account about the facts and feelings surrounding the diagnosis of and battle against lung cancera battle the author waged with every ounce of his being. It has an enlightening quality because he shares how he transformed his previous knowledge of family dynamics, coping strategies, and empowerment into wisdom. He shares his journey of taking the knowledge from the Before Cancer phase of his life, and like an alchemist, converting one raw materialhis life and his diagnosis and battleinto an element quite unlike the original. Robbery and Redemption: Cancer as Identity Theft is chock-full of wisdom that has been learned the old fashioned, visceral wayfrom lived experience and keen reflection. This personal, upfront, rubber-hit-the-road treatise is a gift from the author to each reader. It is his wise interpretation of his own experiences of integrating values, problem solving, and coping strategies.Table of ContentsForeword Acknowledgments INTRODUCTION Read the Introduction now CHAPTER 1 The Dream CHAPTER 2 Through the Looking Glass CHAPTER 3 The Cancer Journey and Detours Along the Way CHAPTER 4 Resolving to Battle the Bully CHAPTER 5 Communicating with Cancer CHAPTER 6 Trying To Be An Exceptional Patient CHAPTER 7 A Cancer Apprentice: Lessons in Redemption EPILOGUE: Remembering Craig Index

    1 in stock

    £66.49

  • Gynaecological Cancer Care

    Ausmed Publications Gynaecological Cancer Care

    1 in stock

    Book SynopsisGynaecological cancers represent the second most common group of cancers and the most common cause of cancer death in woman, but the needs of women with gynaecological cancer are frequently unrecognised and often neglected. A diagnosis of gynaecological cancer can threaten a woman's body image, fertility, sexuality, femininity, relationships, and various roles in life. Nurses and other health professionals who care for women with gynaecological cancer require a resource that covers a range of issues in depth and breadth if they are to provide comprehensive care. This book offers a rich resource of material - presented in a stimulating style. It provides expert, practical, person-centred, evidence-based advice for nurses and other health professionals who care for women with gynaecological cancer.

    1 in stock

    £24.51

  • 1 in stock

    £12.26

  • Cancer and the Search for Selective Biochemical

    Taylor & Francis Inc Cancer and the Search for Selective Biochemical

    1 in stock

    Book SynopsisThe world of medicine has become splintered into two factions, that of orthodoxy and its counterpart, alternative or complementary medicine. A problem with alternative medicine is, of course, that of anecdote and hearsay. The solution: the disclosure, in an unassailable fashion, of the underlying biochemical principles for alternative cancer therapies. Cancer and the Search for Selective Biochemical Inhibitors, Second Edition delineates the underlying biochemical principles for alternative cancer therapies. Completely revised and updated, this edition includes coverage of the link between concepts and practices of alternative and conventional medicine. The author examines anticancer plant substances and other alternatives such as Vitamin C, essiac tea, shark cartilage, and cat's claw. The text also addresses the problem of determining selective and non-toxic enzyme inhibitors for cancer cell metabolic pathways. While an increased number of allopathic professionals are in tTable of ContentsCrossroads. Cancer Origins and Characteristics. Biochemical Insights. Starting at the Genetic Level. Enzymatic Biochemical Treatment Protocols. The Alternative Scene. Surveying Anticancer Plant Substances. On Overcoming the Intractability of Cancer. Cancer Esoterica. The Inhibition of Cancerous Stem Cells. A Summing Up.

    1 in stock

    £171.00

  • Loving Supporting and Caring for the Cancer

    Rowman & Littlefield Loving Supporting and Caring for the Cancer

    1 in stock

    Book SynopsisAt least once in your life someone will say to you, I have cancer, and when she says the three words, you may struggle with a response. If a loved one or friend hasn't informed you of a cancer diagnosis, it's only a matter of time until they will. Every year fourteen million people worldwide learn they are living with or may die from this insidious illness. The uncertainty of cancer causes anxiety in those diagnosed and feelings of inadequacy in loved ones and friends who want to help. When someone says I have cancer, what will you say? More importantly, what will you do? In Loving, Supporting, and Caring for the Cancer Patient, readers will learn specific ways of going beyond the response I'm so sorry, and practical behaviors that will ease a loved one or friend's journey. They range from being specific immediately after a diagnosis, to honoring their loved one or friend at the moment of passing.Based on Stan Goldberg's own cancer journey, thirty years of counseling and coaching peoplTrade ReviewGoldberg dedicates his book to his granddaughter, saying that he hopes her generation 'will find [it] irrelevant and ask, ‘What was cancer, Grandpa?’' Until then, family members and friends of people diagnosed with the disease can use any of his 270 suggestions and principles for helpful behaviors that go beyond just saying, 'I’m so sorry.'.... [Many] are good reminders, such as supporting a loved one’s decision to stop life-extending treatment. Goldberg, a professor emeritus of communicative disorders at San Francisco State and a prolific author, draws heavily and wisely on his experience as a former hospice volunteer. For example, he notes that people often mistakenly think the need to communicate diminishes as people speak less as they approach death. Actually the reverse is true, he says. 'Silence in the dying is less a sign of not wishing to communicate and more a sign of uncertainty, fear, or regret.' He notes that 'dying is not about you' and advises people to grant forgiveness to loved ones who ask for it. Like his other recommendations, this one seems destined to help family members as well as terminal cancer patients feel better. * Booklist *What do you do if a close friend or family members confides to you, 'I have cancer' The news will no doubt knock your world off-kilter — as it did to your loved one’s world, but how can you find solid ground and be the rock of support through what’s to come? In his book, Loving, Supporting, and Caring for the Cancer Patient: A Guide to Caring, Compassion, and Courage, Stan Goldberg, a recognized expert in the area of cancer support, offers 266 suggestions that 'go beyond compassionate intent to helpful behaviors.' ... Goldberg’s valuable book reminds us that the best way to show compassion to our loved ones facing cancer is to show up, to speak from the heart, and to refrain from passing judgment. Essentially, it’s what each of us would want from our loved ones if the tables were turned. * Blogcritics *'Call me if you need anything.' When your friend shared her diagnosis, that was all you could think to say but, of course, she’ll never call because she has cancer and she needs more than six words. What to do? Read Loving, Supporting, and Caring for the Cancer Patient by Stan Goldberg, and learn what really helps.... While it’s true that libraries and bookstores are filled with volumes on cancer, what sets this one apart is that author Stan Goldberg not only works with end-stage cancer patients, but he was a cancer patient himself. That unique both-sides POV is what makes this book most helpful – that, and the fact that Goldberg leaves room for his readers to adjust their caregiving angles. You may note that his ideas are written as 'suggestions,' allowing for different situations and, indeed, different diseases. It’s nice, too, that small chapters are listed individually in the contents, which makes browsing easier. Loving, Supporting, and Caring for the Cancer Patient is one of those books you hope you’ll never need, but would be glad to have when you do. Finding it may be proactive. Owning it is a good call. * Naples Daily News *We often hear about people who are dealing with family members or dear friends who are undergoing cancer treatment. Not only does cancer affect the patient, but it affects everyone that surrounds the patient- both family and friends. It’s a hard concept to deal with. The diagnosis rocks the patient’s world and those surrounding the patient. The patient doesn’t quite know what to do — other than go through treatment– but family and friends often are unaware of or can’t figure out the best ways to assist that person. Talk about a situation where a guide or book would be so helpful for the patient to read as well as anyone/everyone surrounding that patient. Finally someone has written that book! Stan Goldberg, PHD, has an incredible resume/CV to his name that makes him the perfect author for his book: Loving, Supporting, and Caring for the Cancer Patient: A Guide to Communication, Compassion, and Courage. * LA-Story.com *It’s almost inevitable that eventually, you will hear 'I have cancer' from the lips of someone special in your life. Loving, Supporting and Caring for the Cancer Patient can help you provide a gracious, generous reply. * Energy Times *While it’s true that libraries and bookstores are filled with volumes on cancer, what sets this one apart is that author Stan Goldberg not only works with end-stage cancer patients, but he was a cancer patient himself. That unique both-sides POV is what makes this book most helpful – that, and the fact that Goldberg leaves room for his readers to adjust their caregiving angles. You may note that his ideas are written as 'suggestions,' allowing for different situations and, indeed, different diseases. It’s nice, too, that small chapters are listed individually in the contents, which makes browsing easier. Loving, Supporting, and Caring for the Cancer Patient is one of those books you hope you’ll never need, but you’ll glad to have when you do. Finding it may be proactive. Owning it is a good call. * The Clermont Sun *[Goldberg's] ability to describe difficult situations with accuracy and to provide appropriate suggestions on how to deal with sensitive topics, such as end-of-life decisions, will make this book invaluable to many readers. * Lancet *Simply stated, "Loving, Supporting, and Caring for the Cancer Patient: A Guide to Communication, Compassion, and Courage" should be on the Health/Medicine shelf of every community library in this country. Exceptionally well written, organized and presented, it is an ideal instruction manual and guide for the non-specialist general reader wanting to offer emotional support to family members, friends, neighbors, and co-workers having to deal with cancer. * Midwest Book Review *Dr. Goldberg writes lucidly and compassionately about his personal life and his patients’ lives with cancer. He advocates an empowering attitude of adapting to cancer with vigorous treatment including alternative therapies rather than fearfully fighting a battle with anxiety and guilt that can result from its ups and downs. Everyone living with cancer will benefit from his ideas and advice. -- Jack C. Westman, M.D, M.S., author of The Cancer Solution: Taking Charge of Our Life with Cancer; Professor Emeritus, University of Wisconsin School of Medicine and Public HealthThis book offers simple but profound advice for caring for a loved one with cancer. It is a guide to the compassionate response we seek but are often at a loss to provide. It is rich with the wisdom needed to be present at life’s most difficult time. -- Betty Ferrell, PhD, MA, FAAN, FPCN, CHPN, Director, Division of Nursing Research and Education, City of HopeThis book is a must read for persons whose family member has cancer, as the author walks them through the experience from the time of diagnosis to bereavement, complete with many suggestions and illustrations that are truthful and useful. This book will help readers uncover the scary and complex process of the unknown, enabling them to fully embrace the possibility of living through the full course of the cancer journey wisely and compassionately. -- Youngmee Kim, Phd, University of Miami

    1 in stock

    £38.00

  • Communicating with Cancer Patients

    Taylor & Francis Inc Communicating with Cancer Patients

    1 in stock

    Book SynopsisPublished in association with the European Society of Medical Oncology, this book is designed for trainee oncologists, oncology nurses, and those working with cancer patients on a day-to-day basis. Using an accessible writing style suitable for a wide audience of caregivers, the book focuses on the soft skills required in communicating with patients. Topics include the aetiology of cancer, diagnosis and staging, and explaining the purpose of treatment, including chemotherapy, hormone treatment, and immunological and gene-based therapies. The book also discusses patient support groups, monitoring remission, and relapse. Communicating with Cancer Patients is written by UK oncologists but has wide international application.Trade Review"… a super little book. On the whole this is a well written and easy to read text. one that I would recommend … "—Dr Karin Baria, Retired Consuftam Oncologist, Oncology News, Volume 10 Issue 1 - March/ApriI 20 15Table of ContentsIntroduction. The different phases of management. The aetiology of cancer. Diagnosis and Staging. Environment. Referral letter. Results and investigations to date. Observation. History. Examination. Performance status. Investigations. Next steps. Questions. Primary Treatment. Cytotoxic chemotherapy. Hormone treatment. Immunological therapy. Gene-based therapies. Explaining the purpose of treatment. Communication within the Context of Multidisciplinary Care. Oncology nurses. Psychosocial oncologists. Patient support groups and the internet. Explaining Follow-up. Monitoring remission. Relapse. Progression and Terminal Care. Explaining Research. Complementary and Alternative Medicines and Integrative Oncology.

    1 in stock

    £27.99

  • Intraperitoneal Cancer Therapy

    Taylor & Francis Inc Intraperitoneal Cancer Therapy

    1 in stock

    Book SynopsisIntraperitoneal Cancer Therapy: Principles and Practice is one of the first books to combine the latest clinical developments in the treatment of patients with peritoneal surface disease and the scientific principles that underlie the concept of intraperitoneal cancer therapy. The book covers basic concepts such as anatomy, physiology, pharmacology, and mathematical models of drug transport as well as practical clinical applications, highlighted with results from clinical trials and promising novel preclinical developments.The book is a state-of-the-art reference for surgical and medical oncologists interested in the treatment of carcinomatosis. It also establishes and promotes basic and translational research interest in the field of intraperitoneal drug delivery, which has the potential to improve the outcome for this dreaded condition. Edited by two renowned surgical oncologists, it represents the definitive reference in the field of intraperitonealTrade Review"The unique feature of this book is its complete coverage of all essentials for treating peritoneal surface malignancies -- it is truly a "one stop shop"… The quality of this book is superb and the digital version provides an extra dimension. It is unique in the comprehensive coverage of this highly specific topic and cannot readily be compared to other books." - Carlos HF Chan, MD, PhD (University of Iowa Hospitals and Clinics), 5 stars, Doody Enterprises"The unique feature of this book is its complete coverage of all essentials for treating peritoneal surface malignancies -- it is truly a "one stop shop"… The quality of this book is superb and the digital version provides an extra dimension. It is unique in the comprehensive coverage of this highly specific topic and cannot readily be compared to other books." —5 stars (100/100), Carlos HF Chan, MD, PhD (University of Iowa Hospitals and Clinics), Doody's Book Review ServiceTable of ContentsPERITONEUM: EMBRYOLOGY, ANATOMY, AND PHYSIOLOGY. Embryology and Anatomy of the Peritoneal Cavity. Structure and Function of the Mesothelial Cell. Applied Radiological Anatomy of the Peritoneal Cavity. Peritoneal Drug Transport. PERITONEAL CARCINOMATOSIS: BASIC MECHANISMS. Molecular Biology of Peritoneal Carcinomatosis. Dissemination and Adhesion of Peritoneal Cancer Cells to the Peritoneal Wall. Genomic Approaches to Peritoneal Carcinomatosis. Surgery, Wound Healing, and Peritoneal Minimal Residual Disease in Colorectal Cancer. Role of the Greater Omentum in the Pathogenesis of Peritoneal Carcinomatosis. Lymphatic Transport and the Diaphragmatic Stomata. INTRAPERITONEAL DRUG THERAPY: BASIC PRINCIPLES. Pharmacokinetics of Intraperitoneal Cytotoxic Drug Therapy. Tissue Transport and Pharmacodynamics of Intraperitoneal Chemotherapy. Mathematical Models of Intraperitoneal Drug Delivery. SURGICAL TECHNIQUES FOR INTRAPERITONEAL DRUG DELIVERY. Management of Peritoneal Metastases Using Cytoreductive Surgery and Perioperative Chemotherapy. Chemoperfusion Techniques and Technologies. Port Placement for Intraperitoneal Chemotherapy. CLINICAL RESULTS OF INTRAPERITONEAL DRUG DELIVERY. Intraperitoneal Chemotherapy for Ovarian Cancer. Cytoreductive Surgery and HIPEC in the Treatment of Advanced Epithelial Ovarian Cancer and Serous Papillary Peritoneal Carcinoma. Pseudomyxoma Peritonei. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer with Peritoneal Surface Disease. Diffuse Malignant Peritoneal Mesothelioma: Current Concepts in Evaluation and Management. Gastric Cancer and Intraperitoneal Chemotherapy. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Small Bowel Adenocarcinoma. Peritoneal Surface Malignancy from Neuroendocrine Tumors. Treatment Considerations for High-Grade Appendiceal Adenocarcinoma. Systemic Therapy for Appendiceal Cancer. Toxicity and Morbidity of IP Drug Therapy. Safety Considerations and Occupational Hazards. Role of CRS/HIPEC in the Management of Malignant Ascites. NOVEL AND EXPERIMENTAL APPROACHES. Development of Drug-Loaded Particles for Intraperitoneal Therapy. Biomaterials and Drug Delivery Systems for Intraperitoneal Chemotherapy. Intraperitoneal Nonviral Nucleic Acid Delivery in the Treatment of Peritoneal Cancer. Immunotherapy of Peritoneal Carcinomatosis. The Promise of Oncolytic Viral Therapy for the Treatment of Peritoneal Surface Malignancies. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).

    1 in stock

    £190.00

  • Humana Press Inc. Cancer and Sexual Health

    1 in stock

    Book SynopsisThe average physician and even cancer care-givers are not knowledgeable about the effects of cancer treatment on sex and reproductive life. They are even less aware of the options available for treatment of such patients. Cancer and Sexual Health fills a great need for a reference work devoted to the link between cancer and human sexuality. The volume is designed to give a comprehensive and state-of-the-art review of the sexual and reproductive consequences of cancer diagnosis and treatment. It will prove an invaluable resource for those clinicians caring for cancer patients as well as acting as a reference text for the sexual medicine clinician who may not see a large number of cancer patients.Trade ReviewFrom the reviews:“Nearly 100 internationally recognised contributors … collected an impressive amount of information useful for sexual medicine clinicians, urologists and oncologists. The book is divided into five parts. … All pharmacological, nutritional, surgical and psychological strategies were exhaustively considered including current and future options. This outstanding textbook succeeded in its aim and we recommend this as a reference to clinicians involved in cancer management or in urology-andrology for them to obtain valuable information which can be useful in clinical practice.” (European Eurology Today, October/November, 2011)“Cover the issues of sexual function before, during, and after cancer treatment. … appeal to primary care practitioners, surgeons, urologists, gynecologists, psychologists, psychiatrists, endocrinologists, social workers, and lay people. … chapters are so well written and illustrated that a person without a medical background could understand it. … This book should be an important part of the library of every clinician … . an excellent resource and has very broad appeal to numerous specialists, clinicians, and even lay people. There is something here for everyone.” (Jack Henry Mydlo, Doody’s Review Service, July, 2011)Table of ContentsPart I: Normal SEXUAL FUNCTION Functional Anatomy Of The Male Sex Organs Anthony Bella MD Functional Anatomy Of The Female Sex Organs Clare Yang MD Physiology Of Libido Jim Pfaus PhD Physiology Of Orgasm Roy Levin PhD Physiology Of Female Sexual Arousal Irwin Goldstein MD Physiology Of Erection Tom Lue MD Physiology Of Ejaculation Francois Giuliano MD PART II: Disorders of sexual function Classifying Female Sexual Dysfunction Annamaria Giraldi MD Hypoactive Sexual Desire Disorder Alessandra Rellini MD Disorders Of Female Sexual Arousal Tuuli Kukkonen MD Disorders Of Female Orgasm Cindy Meston PhD Sexual Pain Disorders Caroline Pukall PhD Erectile Dysfunction Francesco Montorsi MD Hypogonadism Wayne Hellstrom MD Peyronie's Disease Larry Levine MD Disorders Of Ejaculation And Male Orgasm Chris McMahon MD Priapism Arthur Burnett MD PART III: PATIENT ASSESSMENT The Sexual Health Interview: Male Kevan Wylie MD The Sexual Health Interview: Female Sharon Parish MD Communicating about Sex Susan Carr PhD Validated Questionnaires In Female Sexual Function Assessment Cindy Meston PhD Validated Questionnaires In Male Sexual Function Assessment Ray Rosen PhD & Christian Nelson PhD Evaluation of the Female with Sexual Dysfunction Michael Krychman MD Evaluation of the Male with Sexual Dysfunction Gregory Broderick MD Partner Consequences Of Sexual Dysfunction Eusebio Rubio-Aurioles PhD Sexual Health in Gay & Lesbian PatientsAnne Katz, RN, PhDPART IV: CANCER & SEX Impact of Cancer Diagnosis on Sexual Health Christian Nelson PhD & Andrew Roth MD Breast Cancer Stacy Lindau MD Gynecological Cancers Johannes Bitzer MD Pelvic Surgery for Urological Cancers Nelson Bennett MD & John P. Mulhall MD Pelvic Radiation in Men Luca Incrocci MD Pelvic Radiation in Women Pernille Jensen MD Impact Of Chemotherapy and Hormone Therapy On Female Sexual HealthRosella Nappi MD & Emmanuele Jannini Impact Of Androgen Deprivation Therapy on Male Sexual Health Run Wang MD Colorectal Cancer Klaas Havenga MD Stem Cell Transplant Karen Syrjala PhD Sexual Health in the Terminally Ill Woet Gianotten MD PART V: TREATMENT STRATEGIES Survivorship: An Overview Mary McCabe RN Nutriceuticals in Sexual Health Mark Moyad MD Medical Treatments For Sexual Problems In Women Alessandra Grazziotin MD Surgical Treatments For Sexual Problems In Women Andrew Goldstein MD Sex Therapy In Female Sexual Dysfunction Linda Banner PhD Erectile Function Preservation in the Cancer Patient Raanan Tal MD & John P. Mulhall MD Erectile Dysfunction: Pharmacological Therapy Gerry Brock MD Erectile Dysfunction: Devices Culley Carson MD Management Of Premature Ejaculation Marcel Waldinger MD Testosterone Supplementation In The Male Cancer Patient Abraham Morgentaler MD Sex Therapy In Male Sexual Dysfunction Stan Althof MD Restoring Intimacy In Relationships Affected by Cancer Sharon Manne PhD Dating And Disclosure For Single Cancer Survivors Brad Zebrack MSW

    1 in stock

    £197.99

  • Surgical Oncology

    Taylor & Francis Inc Surgical Oncology

    1 in stock

    Book SynopsisSurgical oncology is now a recognized specialty in the US and several European countries, and cancer surgery takes up a significant part of any general surgeon's workload. This thoroughly updated second edition of this bestseller is officially endorsed as a textbook for the syllabus and curriculum of the UEMS examination in Surgical Oncology, which is administered by ESSO (European Society for Surgical Oncology). The examination is for trainees at the end of training or established consultants seeking to expand their accreditation. Table of ContentsCancer epidemiology. Genetics and hereditary cancer syndromes, genetic polymorphisms and cancer. Clinical trial design in surgical oncology. A critical overview of screening for cancer. Principles of radiation therapy for surgeons. Intraoperative radiotherapy. Principles of systemic therapy for surgeons. Quality assurance in surgical oncology. Palliative care in surgical oncology. Communication and psychological needs of the cancer surgery patient. Nutrition in cancer and cancer surgery. Image-guided surgery. The role of interventional radiology in the management of cancer patients. Minimal access and robotic surgery. Surgery for older cancer patients. Cancer of unknown primary. Oral cancer. Salivary gland tumors. Paranasal sinus cancers. Skull base tumours. Cancer of larynx and hypopharynx. Breast cancer. Lung and pleura. Esophageal cancer. Gastric cancer. Gastrointestinal stromal tumor. Small bowel and appendiceal tumors. Cancer of the colon and rectum. Anal cancer. Peritoneal surface malignancy. Pancreatic and ampullary cancer. Hepatocellular carcinoma. Carcinoma of the biliary tree and gallbladder. Liver metastases. Renal cell carcinoma. Urothelial carcinoma of the bladder and upper tract. Prostate cancer. Testicular tumours. Gynaecological oncology. Skin cancer: Squamous cell carcinoma and basal cell carcinoma. Skin: Melanoma. Thyroid cancer. Adrenal tumours. Parathyroid cancer. Neuroendocrine tumours of the gastrointestinal tract. Bone sarcoma. Extremity soft tissue sarcoma. Retroperitoneal sarcoma. Neurosurgical oncology: Neoplasms of the brain and meninges.

    1 in stock

    £161.50

  • Hyperthermia in Oncology

    Taylor & Francis Inc Hyperthermia in Oncology

    1 in stock

    Book SynopsisHyperthermia in oncology is the application of heat to a patient's body for the purpose of cancer treatment. In recent years, its use has seen rapid development, with a large amount of clinical data becoming available. Hyperthermia in Oncology synthesizes the current research on the topic and provides treatment protocols for using localized as well as whole-body hyperthermia. The differentiating characteristic of this book is the systematic documentation of evidence. Standard procedures for cancer diagnosis, treatment, and management are included along with guidance for evaluating clinical therapeutic effects. The book examines the unique effects of hyperthermia treatment with a large quantity of evidence-based data from both medical research and clinical practice. It reviews outcomes of cancer patients clinically treated at Clifford Hospital, a state-of-the-art facility with Joint Commission International accreditation located in Guangzhou, China.Table of ContentsIntroduction. Overview of Hyperthermia in Oncology. Categories and Methods of Hyperthermia in Oncology. Physical Technology and Biological Basis of Hyperthermia in Oncology. Hyperthermia in Oncology and Nontoxic Integrative Treatments. Clinical Applications of Hyperthermia in Cancer Treatments. Integrative Hyperthermia Treatments for Different Types of Cancer. Nursing Care Techniques on Hyperthermia in Cancer Treatment. Therapeutic Protocols of Integrated Hyperthermia Treatment for Noncancerous Diseases. Bibliography. Appendices.

    1 in stock

    £161.50

© 2026 Book Curl

    • American Express
    • Apple Pay
    • Diners Club
    • Discover
    • Google Pay
    • Maestro
    • Mastercard
    • PayPal
    • Shop Pay
    • Union Pay
    • Visa

    Login

    Forgot your password?

    Don't have an account yet?
    Create account